TickerFacts.

Adaptive Biotechnologies Corp (ADPT): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$16.00M
Year ended 2025-12-31
$20.92M2022-12-31: $20.92M2023-12-31: $19.60M2024-12-31: $17.44M2025-12-31: $16.00M$16.00M
2022-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$16.00M-8.3%2026-02-26, From 2025-01-01
2024-12-31$17.44M-11.0%2026-02-26, From 2024-01-01
2023-12-31$19.60Mn/c2026-02-26, From 2023-01-01
2022-12-31$20.92Mn/a2025-03-03, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Adaptive Biotechnologies Corp (ADPT)2025-12-31$16.00M-8.3%
Vericel Corp (VCEL)2025-12-31$11.54M+109.7%
Iovance Biotherapeutics, Inc. (IOVA)2025-12-31$35.94M-4.4%
Vaxart, Inc. (VXRT)2025-12-31$8.58M-3.1%
Twist Bioscience Corp (TWST)2025-09-30$24.85M-20.9%
Immunocore Holdings plc (IMCR)2025-12-31$3.10M-26.2%
REGENXBIO Inc. (RGNX)2025-12-31$15.62M-3.7%
Ginkgo Bioworks Holdings, Inc. (DNA)2025-12-31$58.99M-6.4%
ADMA Biologics, Inc. (ADMA)2025-12-31$8.10M+0.6%

Compare ADPT, VCEL, IOVA, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗